K. Mark Parnell

1.1k total citations
13 papers, 628 citations indexed

About

K. Mark Parnell is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, K. Mark Parnell has authored 13 papers receiving a total of 628 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 3 papers in Cancer Research and 2 papers in Epidemiology. Recurrent topics in K. Mark Parnell's work include RNA modifications and cancer (6 papers), RNA and protein synthesis mechanisms (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). K. Mark Parnell is often cited by papers focused on RNA modifications and cancer (6 papers), RNA and protein synthesis mechanisms (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). K. Mark Parnell collaborates with scholars based in United States, United Kingdom and New Zealand. K. Mark Parnell's co-authors include Scott A. Strobel, Rachel Green, Joshua S. Weinger, Silke Dorner, Michael V. McCullar, Koc-Kan Ho, Jason M. Foulks, Steven B. Kanner, Rebecca N. Nix and Thomas F. Hendrickson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Molecular and Cellular Biology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

K. Mark Parnell

13 papers receiving 614 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K. Mark Parnell United States 11 530 102 93 84 39 13 628
Annie Bouchard Canada 16 750 1.4× 43 0.4× 66 0.7× 47 0.6× 13 0.3× 22 914
Brian Budke United States 13 707 1.3× 103 1.0× 250 2.7× 70 0.8× 54 1.4× 17 825
Thomas Monecke Germany 12 739 1.4× 35 0.3× 56 0.6× 49 0.6× 17 0.4× 22 805
Anne-Laure Vitte France 10 679 1.3× 55 0.5× 63 0.7× 105 1.3× 9 0.2× 16 771
Toshiaki Tsubota Japan 12 799 1.5× 73 0.7× 87 0.9× 55 0.7× 13 0.3× 12 923
Vladislav A. Malkov United States 16 579 1.1× 110 1.1× 66 0.7× 97 1.2× 17 0.4× 25 797
Maria Mangos Canada 7 1.4k 2.7× 38 0.4× 155 1.7× 47 0.6× 45 1.2× 12 1.5k
Colin W. Garvie United States 15 785 1.5× 66 0.6× 187 2.0× 95 1.1× 50 1.3× 22 953
Susan Cannon‐Carlson United States 10 375 0.7× 57 0.6× 103 1.1× 108 1.3× 26 0.7× 15 517
Torkild Visnes Norway 14 591 1.1× 70 0.7× 176 1.9× 61 0.7× 10 0.3× 23 730

Countries citing papers authored by K. Mark Parnell

Since Specialization
Citations

This map shows the geographic impact of K. Mark Parnell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Mark Parnell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Mark Parnell more than expected).

Fields of papers citing papers by K. Mark Parnell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Mark Parnell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Mark Parnell. The network helps show where K. Mark Parnell may publish in the future.

Co-authorship network of co-authors of K. Mark Parnell

This figure shows the co-authorship network connecting the top 25 collaborators of K. Mark Parnell. A scholar is included among the top collaborators of K. Mark Parnell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Mark Parnell. K. Mark Parnell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Ch’ng, James, K. Mark Parnell, Nicolás M. Reinoso-Vizcaíno, et al.. (2021). Monocarboxylate transporter antagonism reveals metabolic vulnerabilities of viral-driven lymphomas. Proceedings of the National Academy of Sciences. 118(25). 45 indexed citations
2.
Swiatek, Wojciech, K. Mark Parnell, G. Allen Nickols, Bruce F. Scharschmidt, & Jared Rutter. (2020). Validation of PAS Kinase, a Regulator of Hepatic Fatty Acid and Triglyceride Synthesis, as a Therapeutic Target for Nonalcoholic Steatohepatitis. Hepatology Communications. 4(5). 696–707. 8 indexed citations
3.
Parnell, K. Mark, Jason M. Foulks, Rebecca N. Nix, et al.. (2013). Pharmacologic Activation of PKM2 Slows Lung Tumor Xenograft Growth. Molecular Cancer Therapeutics. 12(8). 1453–1460. 55 indexed citations
4.
Foulks, Jason M., Bai Luo, K. Mark Parnell, et al.. (2013). Synthesis and structure–activity relationship of 2-arylamino-4-aryl-pyrimidines as potent PAK1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 23(14). 4072–4075. 14 indexed citations
5.
Xu, Yong, Xiaohui Liu, Michael A. Saunders, et al.. (2013). Discovery of 3-(trifluoromethyl)-1H-pyrazole-5-carboxamide activators of the M2 isoform of pyruvate kinase (PKM2). Bioorganic & Medicinal Chemistry Letters. 24(2). 515–519. 43 indexed citations
6.
Ho, Koc-Kan, K. Mark Parnell, Yi Yuan, et al.. (2012). Discovery of 4-phenyl-2-phenylaminopyridine based TNIK inhibitors. Bioorganic & Medicinal Chemistry Letters. 23(2). 569–573. 23 indexed citations
7.
Foulks, Jason M., K. Mark Parnell, Rebecca N. Nix, et al.. (2011). Epigenetic Drug Discovery: Targeting DNA Methyltransferases. SLAS DISCOVERY. 17(1). 2–17. 117 indexed citations
8.
Parnell, K. Mark & Brenda Bass. (2009). Functional Redundancy of Yeast Proteins Reh1 and Rei1 in Cytoplasmic 60S Subunit Maturation. Molecular and Cellular Biology. 29(14). 4014–4023. 24 indexed citations
9.
Weinger, Joshua S., K. Mark Parnell, Silke Dorner, Rachel Green, & Scott A. Strobel. (2004). Substrate-assisted catalysis of peptide bond formation by the ribosome. Nature Structural & Molecular Biology. 11(11). 1101–1106. 220 indexed citations
10.
Parnell, K. Mark & Scott A. Strobel. (2003). HIS & HERS, magic magnesium and the ballet of protein synthesis. Current Opinion in Chemical Biology. 7(5). 528–533. 4 indexed citations
11.
Parnell, K. Mark, et al.. (2002). Evidence against stabilization of the transition state oxyanion by a pKa-perturbed RNA base in the peptidyl transferase center. Proceedings of the National Academy of Sciences. 99(18). 11658–11663. 25 indexed citations
12.
13.
Jenkinson, Howard F., et al.. (1995). Polypeptides associated with tufts of cell-surface fibrils in an oral Streptococcus. Microbiology. 141(10). 2729–2738. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Annie Bouchard Breakdown of academic impact, for papers by Brian Budke Breakdown of academic impact, for papers by Thomas Monecke Breakdown of academic impact, for papers by Anne-Laure Vitte Breakdown of academic impact, for papers by Toshiaki Tsubota Breakdown of academic impact, for papers by Vladislav A. Malkov Breakdown of academic impact, for papers by Maria Mangos Breakdown of academic impact, for papers by Colin W. Garvie Breakdown of academic impact, for papers by Susan Cannon‐Carlson Breakdown of academic impact, for papers by Torkild Visnes
Rankless by CCL
2026